| Identification of candidate anti-cancer molecular mechanisms of compound kushen injection using functional genomics Z Qu, J Cui, Y Harata-Lee, TN Aung, Q Feng, JM Raison, RD Kortschak, ... Oncotarget 7 (40), 66003, 2016 | 74 | 2016 |
| Effect of compound kushen injection, a natural compound mixture, and its identified chemical components on migration and invasion of colon, brain, and breast cancer cell lines S Nourmohammadi, TN Aung, J Cui, JV Pei, ML De Ieso, Y Harata-Lee, ... Frontiers in oncology 9, 314, 2019 | 60 | 2019 |
| Cell cycle, energy metabolism and DNA repair pathways in cancer cells are suppressed by Compound Kushen Injection J Cui, Z Qu, Y Harata-Lee, T Nwe Aung, H Shen, W Wang, DL Adelson BMC cancer 19, 1-10, 2019 | 44 | 2019 |
| LAG-3 and PD-1 synergize on CD8+ T cells to drive T cell exhaustion and hinder autocrine IFN-γ-dependent anti-tumor immunity LP Andrews, SC Butler, J Cui, AR Cillo, C Cardello, C Liu, EA Brunazzi, ... Cell 187 (16), 4355-4372. e22, 2024 | 39 | 2024 |
| Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment S Onkar, J Cui, J Zou, C Cardello, AR Cillo, MR Uddin, A Sagan, M Joy, ... Nature Cancer 4 (4), 516-534, 2023 | 38 | 2023 |
| The biphasic and age-dependent impact of klotho on hallmarks of aging and skeletal muscle function Z Clemens, S Sivakumar, A Pius, A Sahu, S Shinde, H Mamiya, ... Elife 10, e61138, 2021 | 37 | 2021 |
| IFNγ-induction of TH1-like regulatory T cells controls antiviral responses AM Gocher-Demske, J Cui, AL Szymczak-Workman, KM Vignali, JN Latini, ... Nature immunology 24 (5), 841-854, 2023 | 36 | 2023 |
| An effective drug sensitizing agent increases gefitinib treatment by down regulating PI3K/Akt/mTOR pathway and up regulating autophagy in non-small cell lung cancer J Zhang, Z Qu, H Yao, L Sun, Y Harata-Lee, J Cui, TN Aung, X Liu, R You, ... Biomedicine & Pharmacotherapy 118, 109169, 2019 | 32 | 2019 |
| Understanding the mechanistic contribution of herbal extracts in compound kushen injection with transcriptome analysis H Shen, Z Qu, Y Harata-Lee, TN Aung, J Cui, W Wang, RD Kortschak, ... Frontiers in Oncology 9, 632, 2019 | 28 | 2019 |
| The effect of compound kushen injection on cancer cells: Integrated identification of candidate molecular mechanisms J Cui, Z Qu, Y Harata-Lee, H Shen, TN Aung, W Wang, RD Kortschak, ... PloS one 15 (7), e0236395, 2020 | 22 | 2020 |
| Yiqi Chutan Tang reduces Gefitinib‐induced drug resistance in non‐small‐cell lung cancer by targeting apoptosis and autophagy J Zhang, L Sun, J Cui, J Wang, X Liu, TN Aung, Z Qu, Z Chen, DL Adelson, ... Cytometry Part A 97 (1), 70-77, 2020 | 21 | 2020 |
| Fractional deletion of compound Kushen injection indicates cytokine signaling pathways are critical for its perturbation of the cell cycle TN Aung, S Nourmohammadi, Z Qu, Y Harata-Lee, J Cui, HY Shen, ... Scientific Reports 9 (1), 14200, 2019 | 16 | 2019 |
| Integrated BATF transcriptional network regulates suppressive intratumoral regulatory T cells F Shan, AR Cillo, C Cardello, DY Yuan, SR Kunning, J Cui, C Lampenfeld, ... Science Immunology 8 (87), eadf6717, 2023 | 12 | 2023 |
| A new Strategy for identifying Mechanisms of Drug-drug interaction Using transcriptome Analysis: compound Kushen injection as a proof of principle H Shen, Z Qu, Y Harata-Lee, J Cui, TN Aung, W Wang, RD Kortschak, ... Scientific Reports 9 (1), 15889, 2019 | 6 | 2019 |
| Regulatory T cell insufficiency in autoimmune diabetes is driven by selective loss of neuropilin-1 on intraislet regulatory T cells S Grebinoski, G Pieklo, Q Zhang, A Visperas, J Cui, J Goulet, H Xiao, ... The Journal of Immunology 213 (6), 779-794, 2024 | 2 | 2024 |
| Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment (Mar, 10.1038/s43018-023-00527-w, 2023) S Onkar, J Cui, J Zou, C Cardello, AR Cillo, MR Uddin, A Sagan, M Joy, ... NATURE CANCER 4 (4), 582-582, 2023 | | 2023 |
| 1051 Radiation dose-related temporal changes in STING-associated immune genes in murine CD8 T cells A Torres, A Shea, W Jin, C Kerr, K Schroeder, P Clark, Z Morris Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 810 Novel renal cell carcinoma immunotherapy combining TLR9-targeted STAT3 antisense oligonucleotide with PD-1 blockade M Alcantara, A Chehrazi-Raffle, N Dizman, W Tang, L Meza, Z Zengin, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Interferon Gamma Induction of TH1-like Tregs Controls Anti-viral Responses AM Gocher, J Cui, A Szymczak-Workman, K Vignali, JN Latini, GP Pieklo, ... The Journal of Immunology 208 (1_Supplement), 53.23-53.23, 2022 | | 2022 |
| Research on Compound Kushen Injection (CKI): Anti-cancer Mechanism Pathway/Network structure J Cui | | 2018 |